Cargando…

A review of the clinical utility of duloxetine in the treatment of diabetic peripheral neuropathic pain

Diabetes mellitus is a world-wide epidemic with many long-term complications, with neuropathy being the most common. In particular, diabetic peripheral neuropathic pain (DPNP), can be one of the most distressing complications associated with diabetes, leading to decreases in physical and mental qual...

Descripción completa

Detalles Bibliográficos
Autores principales:	King, Jordan B, Schauerhamer, Marisa B, Bellows, Brandon K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539088/ https://www.ncbi.nlm.nih.gov/pubmed/26309404 http://dx.doi.org/10.2147/TCRM.S74165

Ejemplares similares

Review of duloxetine in the management of diabetic peripheral neuropathic pain
por: Smith, Timothy, et al.
Publicado: (2007)

Duloxetine in the management of diabetic peripheral neuropathic pain
por: Ormseth, Michelle J, et al.
Publicado: (2011)

Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine
por: Zilliox, Lindsay, et al.
Publicado: (2010)

Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain
por: Quilici, Sibilia, et al.
Publicado: (2009)

Comparison of the Efficacy and Safety of Duloxetine and Gabapentin in Diabetic Peripheral Neuropathic Pain: A Meta-Analysis
por: Jiang, Lanying, et al.
Publicado: (2022)

Review of Efficacy and Safety of Duloxetine 40 to 60 mg Once Daily in Patients with Diabetic Peripheral Neuropathic Pain
por: Skljarevski, Vladimir, et al.
Publicado: (2012)

A Prospective Observational Study Comparing the Efficacy and Safety of Duloxetine and Pregabalin in Diabetic Peripheral Neuropathic Pain
por: Shah, Islam, et al.
Publicado: (2022)

Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo
por: Gao, Y, et al.
Publicado: (2015)

Duloxetine in patients with diabetic peripheral neuropathic pain in Japan: a randomized, doubleblind, noninferiority comparative study with pregabalin
por: Enomoto, Hiroyuki, et al.
Publicado: (2018)

Duloxetine and pregabalin in neuropathic pain of lung cancer patients
por: Gül, Şule Karabulut, et al.
Publicado: (2020)

Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial
por: Joharchi, Khojasteh, et al.
Publicado: (2019)

Correction to: Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial
por: Joharchi, Khojasteh, et al.
Publicado: (2019)

Effect of duloxetine on neuropathic pain in patients intolerant to continuous administration of pregabalin
por: Shimada, Yohei, et al.
Publicado: (2017)

Pregabalin, the lidocaine plaster and duloxetine in patients with refractory neuropathic pain: a systematic review
por: Plested, Melanie, et al.
Publicado: (2010)

Correlation between pain response and improvements in patient-reported outcomes and health-related quality of life in duloxetine-treated patients with diabetic peripheral neuropathic pain
por: Ogawa, Kei, et al.
Publicado: (2015)

Evaluation of efficacy and safety of gabapentin, duloxetine, and pregabalin in patients with painful diabetic peripheral neuropathy
por: Devi, Padmini, et al.
Publicado: (2012)

The efficacy of duloxetine depends on spinal cholinergic plasticity in neuropathic pain model rats
por: Kato, Daiki, et al.
Publicado: (2022)

Superiority of duloxetine to placebo in improving diabetic neuropathic pain: Results of a randomized controlled trial in Japan
por: Yasuda, Hitoshi, et al.
Publicado: (2011)

Review of a Study of Duloxetine for Painful Chemotherapy-Induced Peripheral Neuropathy
por: Wickham, Rita
Publicado: (2013)

Duloxetine Inhibits Microglial P2X4 Receptor Function and Alleviates Neuropathic Pain after Peripheral Nerve Injury
por: Yamashita, Tomohiro, et al.
Publicado: (2016)

Randomized, Placebo-Controlled Comparison of Amitriptyline, Duloxetine, and Pregabalin in Patients With Chronic Diabetic Peripheral Neuropathic Pain: Impact on pain, polysomnographic sleep, daytime functioning, and quality of life
por: Boyle, Julia, et al.
Publicado: (2012)

Duloxetine Protects against Oxaliplatin-Induced Neuropathic Pain and Spinal Neuron Hyperexcitability in Rodents
por: Kim, Woojin, et al.
Publicado: (2017)

Rosuvastatin Synergistically Enhances the Antinociceptive Efficacy of Duloxetine in Paclitaxel-Induced Neuropathic Pain in Mice
por: Lobos, Nicolás, et al.
Publicado: (2023)

Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy
por: Wright, Alan, et al.
Publicado: (2010)

Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial
por: Tesfaye, Solomon, et al.
Publicado: (2022)

Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials
por: Sultan, Asquad, et al.
Publicado: (2008)

Efficacy and safety of duloxetine in painful diabetic peripheral neuropathy: a systematic review and meta-analysis of randomized controlled trials
por: Wu, Chung-Sheng, et al.
Publicado: (2023)

Peripheral mechanisms of peripheral neuropathic pain
por: Pacifico, Paola, et al.
Publicado: (2023)

A comparative double-blind randomized study on the effectiveness of Duloxetine and Gabapentin on painful diabetic peripheral polyneuropathy
por: Majdinasab, Nastaran, et al.
Publicado: (2019)

A retrospective, matched cohort study of potential drug-drug interaction prevalence and opioid utilization in a diabetic peripheral neuropathy population initiated on pregabalin or duloxetine
por: Ellis, Jeffrey J, et al.
Publicado: (2015)

Antinociceptive Effects of the Serotonin and Noradrenaline Reuptake Inhibitors Milnacipran and Duloxetine on Vincristine-Induced Neuropathic Pain Model in Mice
por: Katsuyama, Soh, et al.
Publicado: (2014)

Toward Composite Pain Biomarkers of Neuropathic Pain—Focus on Peripheral Neuropathic Pain
por: Diaz, Monica M., et al.
Publicado: (2022)

Duloxetine in the management of chronic musculoskeletal pain
por: Smith, Howard S, et al.
Publicado: (2012)

Efficacy of Pregabalin and Duloxetine in Patients with Painful Diabetic Peripheral Neuropathy (PDPN): A Multi-Centre Phase IV Clinical Trial—BLOSSOM
por: Rakusa, Martin, et al.
Publicado: (2023)

Topical Fisionerv® is effective in treatment of peripheral neuropathic pain
por: Angelo, Tarullo, et al.
Publicado: (2019)

Pregabalin in the Treatment of Peripheral and Central Chronic Neuropathic Pain
por: Prnjavorac, Besim, et al.
Publicado: (2023)

Tapentadol extended release in the management of peripheral diabetic neuropathic pain
por: Vadivelu, Nalini, et al.
Publicado: (2015)

Effects of alkaloids on peripheral neuropathic pain: a review
por: Zhu, Chunhao, et al.
Publicado: (2020)

Recommendations for Neuromodulation in Diabetic Neuropathic Pain
por: Olmsted, Zachary T., et al.
Publicado: (2021)

Effectiveness of Duloxetine for Postsurgical Chronic Neuropathic Disorders after Spine and Spinal Cord Surgery
por: Tsuji, Osahiio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_onbntusqojb6s2bad5li05g3ep